Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 6 of 6 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dupilumab | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬1. Dupilumab
| [1] IL4R IL4R 💬1. Dupilumab
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, ... | [5] 51 51, 97, 98, 160, 162 💬
| ||||||||||||
| 2 | Dupilumab (blinded) | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬2. Dupilumab (blinded)
| [1] IL4R IL4R 💬2. Dupilumab (blinded)
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, ... | [1] 98 98 💬2. Dupilumab (blinded)
| ||||||||||||
| 3 | Dupilumab (open-label) | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬3. Dupilumab (open-label)
| [1] IL4R IL4R 💬3. Dupilumab (open-label)
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, ... | [1] 98 98 💬3. Dupilumab (open-label)
| ||||||||||||
| 4 | Dupilumab 300Mg Solution for Injection | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬4. Dupilumab 300Mg Solution for Injection
| [1] IL4R IL4R 💬4. Dupilumab 300Mg Solution for Injection
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, ... | [1] 51 51 💬4. Dupilumab 300Mg Solution for Injection
| ||||||||||||
| 5 | Dupilumab Injection | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬5. Dupilumab Injection
| [1] IL4R IL4R 💬5. Dupilumab Injection
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, ... | [1] 160 160 💬5. Dupilumab Injection
| ||||||||||||
| 6 | Dupilumab Prefilled Syringe | [1] Dupilumab Dupilumab (Dupilumab) | [1] Dupilumab
Dupilumab
(Dupilumab, Dupilumab) 💬6. Dupilumab Prefilled Syringe
| [1] IL4R IL4R 💬6. Dupilumab Prefilled Syringe
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, ... | [1] 160 160 💬6. Dupilumab Prefilled Syringe
|